Dagmar Schumacher, PhD

spent 12 years of her career in basic pharmacological research in the cardiovascular, diabetes and cancer disease areas at the Max Planck Institute for Heart and Lung Research and as an assistant professor at the University of Heidelberg, Germany. She joined Roche Diagnostics in 2019 to support point-of-care projects around coagulation and SARS-CoV-2. She then moved into her current position in cardiometabolism, where she works as a scientific partner in Medical and Scientific Affairs, a non-commercial division of Roche.